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Abstract
Background: Amyloidogenic proteins are most often associated with neurodegenerative diseases such as
Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease, but there are more than two dozen human
proteins known to form amyloid fibrils associated with disease. Lysozyme is an antimicrobial protein that is used as
a general model to study amyloid fibril formation. Studies aimed at elucidating the process of amyloid formation of
lysozyme tend to focus on partial unfolding of the native state due to the relative instability of mutant
amyloidogenic variants. While this is well supported, the data presented here suggest the native structure of the
variants may also play a role in primary nucleation.
Results: Three-dimensional structural analysis identified lysozyme residues 21, 62, 104, and 122 as displaced in both
amyloidogenic variants compared to wild type lysozyme. Residue interaction network (RIN) analysis found greater
clustering of residues 112–117 in amyloidogenic variants of lysozyme compared to wild type. An analysis of the
most energetically favored predicted dimers and trimers provided further evidence for a role for residues 21, 62,
104, 122, and 112–117 in amyloid formation.
Conclusions: This study used lysozyme as a model to demonstrate the utility of combining 3D structural analysis
with RIN analysis for studying the general process of amyloidogenesis. Results indicated that binding of two or
more amyloidogenic lysozyme mutants may be involved in amyloid nucleation by placing key residues (21, 62, 104,
122, and 112–117) in proximity before partial unfolding occurs. Identifying residues in the native state that may be
involved in amyloid formation could provide novel drug targets to prevent a range of amyloidoses.
Keywords: Amyloidosis, Lysozyme, Residues interaction networks, Native structure, B-factor

Background
Amyloidoses are a group of diseases defined by the formation of protein aggregates characterized by stacks of
cross-beta sheets [1]. There are dozens of different amyloid diseases caused by a variety of both wild type (WT)
and mutant forms of proteins [2]. Some of the most
well-known amyloidoses are neurodegenerative diseases
such as Alzheimer’s disease (involving amyloid-beta peptide) and Parkinson’s disease (involving alpha-synuclein
protein). However, not all amyloid diseases affect the
brain. Lysozyme amyloidosis is a rare disease characterized by the deposition of amyloid fibrils of the enzyme
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lysozyme. Lysozyme was discovered by Alexander Fleming in 1922 [3] and is an antimicrobial enzyme synthesized by hepatocytes, cells of the gastrointestinal system,
and macrophages [4]. Lysozyme amyloidosis has no
known effective treatment and leads to lysozyme amyloid deposits typically concentrated in the liver [5],
spleen, gastrointestinal tract [6], and kidneys [7]. Lysozyme amyloidosis is thought to be largely caused by subtle structural changes of the protein caused by genetic
mutations that lead to pockets of local instability and a
greater likelihood of partial unfolding [8]. The Online
Mendelian Inheritance in Man (OMIM) database [9]
entry for lysozyme (OMIM ID 153450) reports four lysozyme variants that are associated with the disease: I56T
[10], D67H [10], W64R [11], and F57I [12].
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Lysozyme has long been used as a model for studying
protein structure and folding. Since lysozyme is structurally
and functionally well-characterized, the protein provides a
useful model for understanding the complex process of
amyloid fibril formation [13]. Several studies have investigated the role of amyloidogenic mutations on lysozyme
amyloid formation with a focus on the first identified mutations, I56T and D67H. Studies that examined the crystal
structure of the WT and I56T variant suggest very little difference in the native structure of these enzymes [14]. The
D67H variant, however, destroys the hydrogen bonds that
stabilize the beta-domain, leading to the displacement of a
long loop of residues [15]. Because the obvious loop displacement between the WT and D67H mutant is not
present in the I56T mutant, it is thought that this change is
not responsible for amyloidogenesis. Instability of the I56T
variant may be caused by subtle changes in bonding between alpha and beta domains of lysozyme; similar bonding
changes are also evident in the D67H variant [15].
Since the structure of proteins in amyloid plaques are
different from the native structure, amyloidogenic proteins must at least partially unfold during amyloidogenesis. Most studies focus on the unfolding process of
lysozyme instead of differences in the native structure.
The amyloidogenic proteins likely spend more time partially unfolded, providing more opportunities for unfolded segments to interact and aggregate in the form of
amyloid plaques [8]. The importance of the partially unfolded state for lysozyme amyloidosis has been demonstrated in vitro with the use of antibodies that stabilize
the protein [16, 17]. Studies have also shown that both
I56T and D67H are less stable than WT lysozyme when
heated [15], and I56T is also less stable than WT at low
pH [14, 15, 18, 19], further supporting a role for instability. However, other factors besides regions of protein instability may be involved in amyloidogenesis. Further
studies that examine primary nucleation from different
perspectives could provide more insight into this important process that is associated with a variety of
diseases.
Residue interaction networks (RIN) abstract protein
structure into a network of likely side-chain interactions
with residues represented as nodes and interactions represented as edges, the connections between the nodes [20].
Several metrics are available for studying networks and
identifying subnetworks of interest [21–23]. Many network features have been associated with and applied to
protein structural and functional characteristics [22, 24–
26], demonstrating the relevance of RINs to structural
biology. Clusters are particularly interesting in RIN analysis because they identify areas with many chemical interactions, suggesting structural rigidity or functional
importance [27]. RIN analysis is most useful when combined with 3D structural analysis [28]. This study uses the
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two-pronged approach of combining 3D structural analysis with RIN analysis to identify residues in the native
structure that are likely involved in amyloid formation.

Methods
Three-dimensional structure visualization and structure
comparison

The Online Mendelian Inheritance in Man (OMIM)
database [9] was searched for mutations in lysozyme that
have been associated with amyloidosis. The Protein Data
Bank (PDB) [29] was then searched for human lysozyme
structures with these mutations, resulting in a dataset of
WT human lysozyme (PDB ID: 1REX, [30]) and two
amyloidogenic variants, I56T (PDB ID: 1LOZ, [15]) and
D67H (PDB ID: 1LYY, [15]). The 3D protein structure
coordinates were downloaded from the PDB and visualized using UCSF Chimera v1.11.2 software [31]. The 3D
structures were overlapped using the MatchMaker application [32] in UCSF Chimera with default settings, and
the root mean square deviations (RMSDs) for the full
residues from the wild type (1REX) structure of lysozyme were calculated in the Multialign Viewer [32]. Side
chains that had different locations when compared to
WT lysozyme in both amyloidogenic variants were selected for further study. Because the resolution of the
PDB files used for the comparison was less than or equal
to 1.8 Å, only residues with a RMSD from WT greater
than or equal to 1.9 Å were considered.
Generating residue interaction networks and calculating
clusters and metrics

To detect network clusters in the proteins, the PDB files
were converted to GML format using the Protein Graph
Converter software from the Protein Graph Repository
(PGR) [33]. Each alpha carbon was considered a node,
and an edge was drawn between every alpha carbon
within seven angstroms of another. The GML files were
then analyzed for clusters using the MCODE application
in the network analysis software Cytoscape v3.4.0 [34].
Only clusters with MCODE scores greater than or equal
to 5.00 were selected for further analysis. The residues
involved in the clusters in the amyloidogenic mutants
were compared to those identified in WT lysozyme. As
with the 3D structure comparison, cluster changes that
are in common between the amyloidogenic mutants and
different from WT lysozyme were selected for further
analysis. UCSF Chimera was used to calculate the average residue B-factor for each of the clusters. The Pearson correlation of MCODE scores for the selected
clusters of each of the lysozyme PDB files with the average B-factor for the clusters was calculated using GraphPad Prism 7, and a p-value of < 0.05 was considered
significant.

Griffin and Bradshaw BMC Structural Biology (2018) 18:9

Generating predicted dimer and trimer structures and
calculating interprotein bond number and energies

ClusPro v2.0 software [35] was used to generate predicted
structures of homodimers, homotrimers, and heterodimers for WT lysozyme and the amyloidogenic variants.
After multimer generation, the resulting PDB files for the
top predicted dimer and trimer structures were edited so
that each lysozyme protein was given a unique name.
Next, the edited PDB files were uploaded to the Residue
Interaction Network Generator (RING) v2.0 software [36],
and residue interaction networks were created using a
strict distance threshold between the closest atoms of residues separated by at least two other residues. Multiple
edges per residue pair were allowed but only one edge per
interaction type. The resulting graph files were analyzed
for the number of interactions and overall bonding energy
occurring between lysozyme proteins in dimers or trimers.
The number and bond energies of the interprotein interactions were analyzed for the whole complexes and the
residues of interest to provide information about the relative importance of the residues of interest to the formation
of dimers and trimers.

Results
Three-dimensional structural comparison of lysozyme

Three-dimensional structure overlaps from the
MatchMaker software revealed residues of the amyloidogenic variants that differed from WT lysozyme.
The D67H variant diverges more from WT lysozyme
than the I56T variant. However, there are only four
residues with a RMSD greater than or equal to 1.9 Å
that were shared by both the I56T and the D67H
amyloidogenic lysozyme variants: residues 21, 62, 104
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and 122. In all four cases, the structural changes are
in proximity to each other in the 3D structure
(Fig. 1).

Residue interaction network clustering analysis of
lysozyme structures

The 3D structure of lysozyme and its resulting PGR
residue interaction network (RIN) representation are
shown in Fig. 2. The MCODE application in Cytoscape revealed four clusters in each of the lysozyme
structures that had an MCODE score of greater than
5.00. Some of the clusters in each of the lysozyme
variants involved similar or identical sets of residues.
As before, we focused on the differences from the
WT clusters that were present in both amyloidogenic
proteins. The most robust and consistent difference
was the cluster around residues 112–117. The
MCODE score for the cluster containing these residues in WT lysozyme was 5.11, but it increased in
both amyloidogenic variants to 6.00. Residues 104
and 106–108 are clustered with 112–117 in WT lysozyme but not in I56T and D67H. The average B-factors of the clusters containing residues 112–117 also
decreased in both amyloidogenic variants compared
to WT lysozyme. These results are shown in Table 1.
Residues 112–117 are shown in Fig. 1. There was a
statistically significant negative correlation (r2 = 0.44,
p = 0.0184) between MCODE scores for the top four
clusters in each of the three lysozyme network structures and the average B-factor for each cluster. The
residues are in proximity to the other residues of
interest as shown in Fig. 1.

Fig. 1 Three-dimensional overlap of lysozyme structures 1REX (WT, tan), 1LOZ (I56T, orange), and 1LYY (D67H, blue). The side chains of residues
21, 62, 104, 112–117, and 122 are shown and outlined in green
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Fig. 2 a Three-dimensional WT lysozyme, PDB 1REX. b Network representation of WT lysozyme with amino acids represented as nodes and
edges drawn between alpha carbons within seven angstroms of each other. Residue numbering only for this image starts at zero

Table 1 RIN clusters in WT and amyloidogenic variants of lysozyme
Lysozyme Structure

Cluster Rank

MCODE Score

Residues Involved

WT

Average Residue B-Factor
14.88

1

6.36

92–103

12.35

2

6.00

32–37

11.71

3

5.60

7–13, 19, 23–29, 31

9.72

4

5.11

104, 106–108, 112–117

19.09

1

6.00

112–117

17.53

I56T

16.06

2

6.00

92–98

10.54

3

5.60

7–13, 19, 23–29, 31

10.39

4

5.00

122–126

29.15

D67H

13.24
1

6.50

92–100

7.83

2

6.00

112–117

14.99

3

6.00

32–37

8.21

4

5.75

7–13, 17–19, 23, 25–29, 31

8.12
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Interprotein bonds involving residues 21, 62, 104, 112–
117, and 122 in predicted lysozyme dimers and trimers

The top-rated ClusPro models of dimer and trimer
structures for each of the variants of lysozyme are
shown in Fig. 3 (homodimers), Fig. 4 (homotrimers),
and Fig. 5 (heterodimers). The number of interprotein
residue interactions and the strength of the bonding
energy for these interactions for all residues and for
the residues of interest were quantified using RING
2.0 software, and the results are shown in Table 2
(homodimers), Table 3 (homotrimers), and Table 4
(heterodimers).
For homodimers, residues of interest made up 36% of
the number of interprotein residue interactions in WT

Fig. 3 Predicted 3D structures of WT or mutant lysozyme
homodimers. a WT: WT, (b) I56T: I56T, and (c) D67H: D67H. The side
chains of residues 21, 62, 104, 112–117, and 122 are shown and
outlined in green

Fig. 4 Predicted 3D structures WT or mutant lysozyme homotrimers.
a WT: WT: WT, (b) I56T: I56T: I56T, and (c) D67H: D67H: D67H. The
side chains of residues 21, 62, 104, 112–117, and 122 are shown and
outlined in green

Griffin and Bradshaw BMC Structural Biology (2018) 18:9
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Trimers showed different trends from the homodimers
(Table 3). The total number of interprotein residue interactions increased for I56T (133 interactions) and D67H
(108 interactions) compared to WT (89 interactions).
The contribution of the residues of interest to the total
number of interprotein residue interactions increased
from 2.2% for WT to 55.6% for I56T and 22.2% for
D67H. Interprotein bonding energy showed similar
trends. The total interprotein bonding energy increased
from 824.8 kJ/mol in the WT to 1392.8 kJ/mol in I56T
and 1060.8 kJ/mol in D67H. Residues of interest contributed 1.5% of the total interprotein bonding energy in the
WT but 58.7% in I56T and 30.2% in D67H.
Heterodimers (WT: I56T and WT: D67H) showed
fewer and less energetic interprotein interactions than
homodimers (Table 4). The WT: I56T heterodimer had
48 interprotein interactions and 481 kJ/mol interprotein
bonding energy, and the WT: D67H heterodimer had 49
interprotein interactions and 482.6 kJ/mol bonding energy. In both cases, there was a high reliance on the residues of interest for the bonding. The residues of interest
made up more than 50% of the number of interprotein
bonding interactions and nearly 50% of the interprotein
bonding energies of both heterodimers.

Discussion
Three-dimensional structural comparison suggests
residues 21, 62, 104, and 122 may be involved in
lysozyme amyloidogenesis

Fig. 5 Predicted 3D structures of heterodimers of each of the
amyloidogenic lysozyme variants with WT lysozyme. a WT: I56T, (b)
WT: D67H. The side chains of residues 21, 62, 104, 112–117, and 122
are shown and outlined in green

lysozyme, contributing to 39.1% of the predicted interprotein bonding energy. The overall number of interprotein residue interactions increased to 49.3% of the total
in I56T, but it decreased to 29.5% of the total number in
D67H. However, the total percentage of interprotein
bonding energy contributed by the residues of interest
increased for both amyloidogenic variants even though
the total interprotein bonding energy for dimers was less
than WT dimers.

Comparing 3D protein structures revealed that both
amyloidogenic variants of lysozyme analyzed differ from
WT lysozyme in the location of residues 21, 62, 104, and
122. Following the reasoning of Booth and colleagues
[15], because these differences are common to both
amyloidogenic variants, they suggest these residues may
play a role in the formation of amyloid fibrils. The four
residues (21, 62, 104, and 122) are in proximity to each
other in all three variants (Fig. 1). As discussed above,
the prevailing hypothesis for lysozyme amyloidosis is
that the mutations disrupt the hydrogen bonds near the
residues between alpha and beta domains, leading to
partial unfolding followed by fibril formation [8, 19, 37];
interprotein interactions between the native structures
are not thought to play a large role. However, the
consistency of the native structure changes observed in
both amyloidogenic variants hints at a role for the

Table 2 ClusPro predicted interprotein binding energies for WT and mutant lysozyme homodimers
Lysozyme
Structure

Number of Interprotein Residue Interactions

Interprotein Bond Energy (kJ/mol)

Total

Residues of Interest (% of Total)

Total

Residues of Interest (% of Total)

WT

100

36 (36%)

1019

398 (39.1%)

I56T

71

35 (49.3%)

768

442 (57.6%)

D67H

61

18 (29.5%)

594.6

246 (41.4%)
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Table 3 ClusPro predicted interprotein binding energies for WT and mutant lysozyme homotrimers
Lysozyme
Structure

Number of Interprotein Residue Interactions
Total

Residues of Interest (% of Total)

Total

Residues of Interest (% of Total)

WT

89

2 (2.2%)

824.8

12 (1.5%)

I56T

133

74 (55.6%)

1392.8

817 (58.7%)

D67H

108

24 (22.2%)

1060.8

320 (30.2%)

residues in the native structure in amyloidosis. We hypothesized that these residues may facilitate an interprotein interaction between native state amyloidogenic
lysozyme proteins, contributing to the first steps of
amyloidosis. To gather further support for this hypothesis, we examined the structures for network cluster
changes.
Residues 112–117 may also be involved in lysozyme
amyloidogenesis

In addition to the 3D structural changes described above,
amyloidogenic variants of lysozyme were associated with
changes in network clusters. The network cluster consisting of residues 112–117 of I56T and D67H had the greatest and most consistent cluster changes, showing an
increased MCODE score in both variants compared to
WT (Table 1). Residues 104 and 106–108 were included
in the cluster containing residues 112–117 in WT lysozyme only, so the loss of this part of the cluster may also
have structural implications. More clustering has been
shown to be associated with greater structural stability
[27, 38], so we hypothesized that residues 112–117 have
greater structural stability in the amyloidogenic variants
compared to WT lysozyme. To test this hypothesis, we
used UCSF Chimera to calculate the average B-factor for
each of the residues in each of the PDB files. The B-factor
is a measure of flexibility where a lower B-factor indicates
greater stability [39]. Even in our relatively small data set
of three lysozyme structures, we found a statistically significant negative correlation (r2 = 0.44, p = 0.0184) between MCODE scores and average B-factors for the top
four clusters of each of the PDB files shown in Table 1.
Consistent with the hypothesis of greater cluster stability,
residues 112–117 had smaller average B-factors in amyloidogenic variants compared to the cluster containing these
residues in WT lysozyme. Because most studies focus on
the instability caused by amyloidogenic mutations, disrupting this cluster while stabilizing other regions may
provide a novel therapeutic approach. The side chains of

Interprotein Bond Energy (kJ/mol)

residues 112–117 are shown in Fig. 1 along with the other
residues of interest (21, 62, 104, and 122) from 3D structural comparison. Residues 112–117 are in proximity to
the residues identified through 3D structural comparison.
Therefore, residues 112–117 may also be involved in facilitating interactions between different lysozyme molecules and possibly contribute to primary nucleation of
amyloid fibrils. To test this hypothesis, we simulated intermolecular interactions between native state structures.
Predicted dimer and trimer structures provide further
evidence for the involvement of residues 21, 62, 104,
112–117, and 122 in lysozyme amyloidogenesis

To test the hypothesis that residues 21, 62, 104, 112–
117, and 122 in the structure of amyloidogenic lysozyme
variants are involved in primary nucleation, we used
ClusPro docking software to predict the 3D structure of
dimers and trimers of lysozyme for the PDB files. While
ClusPro generates the structures of many predicted dimers and trimers, we only analyzed the top-ranked
structures. Visual inspection of the predicted homodimers (Fig. 3) suggested some of the residues of interest
may be involved in dimer interactions. To test this hypothesis, we examined the number and strength of interprotein residue interactions (Table 2). The number of
interprotein bonds was less for amyloidogenic variant
homodimers, and there was no consistent trend with the
percent contribution of the residues of interest to the
number of interprotein bonds in the dimers. Both amyloidogenic variant homodimers had overall less bonding
energy. However, the residues of interest contributed to
a greater degree to the interprotein bonding energy
compared to WT lysozyme. Overall, the contribution of
the residues of interest to lysozyme homodimer formation in amyloidogenic variants was not as convincing as
the evidence for their role in simulated trimer
formation.
Visual inspection of the predicted trimer structures of
lysozyme suggested a greater role for the residues of

Table 4 ClusPro predicted interprotein binding energies for WT and mutant lysozyme heterodimers
Lysozyme
Structures

Number of Interprotein Residue Interactions

Interprotein Bond Energy (kJ/mol)

Total

Residues of Interest (% of Total)

Total

Residues of Interest (% of Total)

WT: I56T

48

25 (52.1%)

481

238 (49.5%)

WT: D67H

49

27 (55.1%)

482.6

289.6 (60.0%)
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interest in interprotein interactions of amyloidogenic
variants than WT lysozyme (Fig. 4). When examined
quantitatively, both amyloidogenic variants had stronger
and more numerous bonds between proteins compared
to WT (Table 3). This suggests the residues of interest
may be largely facilitating the predicted sharp increase
in interprotein interactions, supporting the important
role predicted for these residues by 3D structural analysis and network analysis.
A role for mutant native structure in enhancing lysozyme
amyloid fibril formation?

Taken together, these data support the hypothesis that
residues 21, 62, 104, 112–117, and 122 in the mutant native states are involved in lysozyme amyloid primary nucleation. While the instability of amyloidogenic variants
of lysozyme is almost certainly the most important factor for fibril formation [40], it may not be the only factor
involved. The greater interprotein interactions predicted
to occur between trimeric amyloidogenic mutants compared to WT lysozyme may lead to amyloidogenic variants oligomerizing more readily before unfolding. We
hypothesize these aggregates are composed of mostly
mutant proteins because heterodimers with WT lysozyme have less interprotein bonding energies than mutant homodimers. This suggests when one of the
lysozyme variants partially unfolds, it may already be in
proximity to or bound to another mutant molecule,
leading to a greater probability of amyloid nucleation.
The sequence of events of the unfolding process for WT
lysozyme and the I56T variant are consistent with our
hypothesis. It has been demonstrated that lysozyme
alpha helices A, B, and D [41] are some of the last regions to unfold [42]. All the residues identified in this
report except residue 62 are in or near regions of the
protein that unfold later in the process, so these positions have a greater chance of maintaining their structure to facilitate intermolecular interactions during this
process.
Furthermore, Ahn and colleagues concluded that mutations in the alpha domain of lysozyme are less likely to
influence the formation of transient intermediate states
compared to mutations in the beta domain [43]. The resistance of changes in the alpha domain to form transient intermediates is largely consistent with our findings
which suggest subtle changes in the position and interactions of residues 21, 62, 104, 112–117, and 122 (largely
in the alpha domain) play a role in the early steps of primary nucleation before significant unfolding of the alpha
domain occurs. Sequence-based predictions of “hot
spots” of aggregation using Aggrescan [44] and TANGO
[45] suggest sequences in both the alpha and beta domains may be important for amyloid formation. While
we also report a role for residues in the alpha domain,
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the residues identified here are not all included in the
results of the sequence-based predictions. This may be
because we predict residues 21, 62, 104, 112–117 and
122 to play a role in amyloidogenesis prior to the formation of unfolded intermediates by positioning lysozyme
mutants in or near the native state close to each other.
Because this is predicted to occur before significant
unfolding and fibrillization of lysozyme, it is understandable that sequence-based algorithms did not identify the
same residues. Fibrillization is a multistep process, and
it is likely that different residues may be involved in different steps.
Residues 21, 62, 104, and 122 do not appear to be involved in increasing the flexibility of lysozyme in the
amyloidogenic mutants because the total predicted bond
energies from RING analysis for monomers do not suggest consistent and structurally important differences
when compared to WT. Furthermore, the average B-factors for these residues in mutant lysozyme do not consistently differ from WT. It has been suggested that
residues not present in the partially unfolded region can
be altered without affecting the process of amyloid fibril
formation [46], but our data challenge this suggestion. It
has been noted that lysozyme amyloid plaques are nearly
entirely composed of the amyloidogenic variant free
from WT protein [18]. This may be due not only to the
greater instability of amyloidogenic proteins, but also
due to the predicted favored intermolecular interactions
of homodimers and homotrimers compared to heterodimers (Table 4). A better understanding of the process of
amyloidogenesis for lysozyme could yield insights into
treatments for many different types of amyloidoses.
Study limitations and future studies

Data from various computational approaches used in
this study support a role for lysozyme residues 21, 62,
104, 112–117, and 122 in lysozyme amyloidosis. However, this study has several limitations. The most obvious
limitation is the small sample size of 3D structures used.
Unfortunately, the study is limited by the availability of
PDB files of human amyloidogenic lysozyme variants.
We draw our conclusions from three PDB files, making
this a preliminary study. The findings reported here may
not be shared by all amyloidogenic variants of lysozyme.
To increase confidence in our conclusions, further studies should explore the structures of WT and amyloidogenic lysozyme under various experimental conditions.
In addition, it was found that different software programs predicted different lowest-energy oligomeric
structures that influence results. Furthermore, these hypotheses need to be experimentally tested to verify the
importance of these residues for amyloidogenesis. Lysozyme mutants with smaller side chains or nonpolar side
chains at the residues of interest could be created and
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the fibril formation kinetics studied. Data from studies
of double mutants may also be useful. Future studies
could be performed where residues 21, 62, 104, 112–
117, or 122 are mutated in combination with I56T or
D67H and tested for altered fibril formation kinetics.
However, it may be most useful to mutate residue 21
and a residue in 112–117 or 122 because residues 32
through 108 have been shown to form the core of the
lysozyme fibril [47]. Therefore, mutating these residues
may interfere with amyloid formation after unfolding.

Conclusions and testable hypotheses generated
This preliminary study used a combination of 3D structural and residue interaction network analyses to support roles for residues 21, 62, 104, 112–117, and 122 in
lysozyme amyloidosis. By comparing two amyloidogenic
variants to WT lysozyme, we were able to identify network and 3D structural changes that were shared between the amyloidogenic variants. Modeling dimer and
trimer interactions further supported a role for these
residues. These residues appear to be especially important for trimer formation. This study generates several
hypotheses that can be experimentally tested. 1) Residues 112–117 are less flexible in amyloidogenic variants
of lysozyme than in the WT. 2) Residues 21, 62, 104,
112–117, and 122 are involved in the primary nucleation
of lysozyme by facilitating intermolecular interactions
between mutant lysozyme molecules. 3) Trimers of lysozyme are more stable than dimers. 4) Lysozyme mutant
molecules favor self-interactions over interactions with
WT molecules. 5) Interprotein interactions in or close
to the native state likely play a larger role in amyloid formation in general than previously hypothesized. This
study demonstrates the utility of combining 3D structural and network analysis for understanding amyloid
formation. Furthermore, it provides insight into lysozyme amyloid formation that may be applicable to the
study of many other amyloidoses.
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